Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide era. [electronic resource]
Producer: 20121119Description: e33684 p. digitalISSN:- 1932-6203
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Alkylating -- therapeutic use
- Dacarbazine -- analogs & derivatives
- Female
- Glioblastoma -- drug therapy
- Humans
- Male
- Middle Aged
- PTEN Phosphohydrolase -- metabolism
- Phosphatidylinositol 3-Kinases -- metabolism
- Prognosis
- Proto-Oncogene Proteins c-akt -- metabolism
- Retrospective Studies
- Signal Transduction
- Survival Analysis
- Temozolomide
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.